BioSpecifics (BSTC) Reports Positive Top-Line Data from XIAFLEX Phase III in Peyronie's Disease

Go back to BioSpecifics (BSTC) Reports Positive Top-Line Data from XIAFLEX Phase III in Peyronie's Disease